In this free webinar, attendees will learn about the value of a well-planned electronic clinical outcome assessment (eCOA) strategy implemented early in a clinical development program, including how to comply with the latest FDA guidance on oncology patient-reported outcomes. The featured speakers will also share ECG best practices for assessment of drug-induced QT prolongation and the unique challenges in oncology development. Additional topics will include the role of cardiac imaging to detect changes in cardiac function, as well as BP monitoring as a safety measure. Finally, the speakers will discuss the role of centralized imaging collection and evaluation to optimize data quality in oncology development programs.
TORONTO, June 11, 2025 /PRNewswire-PRWeb/ -- Oncology clinical trials are constantly evolving, placing greater demands on development teams to generate high-quality, patient-centered data that meet the expectations of regulators, clinicians, payers and patients alike.
In this upcoming webinar, scientific specialists will share how a holistic endpoint strategy spanning electronic clinical outcome assessment (eCOA), cardiac safety and medical imaging can strengthen trial outcomes, accelerate development and enhance patient impact. Attendees will gain practical insights into building an integrated approach that captures meaningful endpoints, supports regulatory success and maximizes the value of oncology programs from early to late phase.
Attendees will learn how early implementation of eCOA, in alignment with the latest FDA guidance, ensures regulatory compliance while capturing meaningful patient-reported outcomes, helping to differentiate a drug.
The webinar will also address key cardiac safety considerations, including ECG best practices for QT assessment, the role of cardiac imaging and blood pressure monitoring to detect early signs of treatment-related risk.
In addition, the session will highlight the impact of centralized imaging in oncology trials, offering greater consistency and reduced bias versus site-based assessments. Attendees will discover how to optimize data quality and support informed decision-making in oncology clinical trials.
Register for this webinar now to learn how an integrated endpoint strategy can drive better outcomes in oncology clinical development.
Join experts from Clario, Todd Rudo, MD, EVP, Chief Medical Officer; Thomas Moll, PhD, MBA, Senior Scientific Advisor; Fabian Chen, MD, PhD, VP and Deputy CMO, Cardiology; and Anu Bansal, MD, MS, Vice President, Medical Imaging Oncology, for the live webinar on Wednesday, June 25, 2025, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Oncology Clinical Development: Optimizing Value Through Implementation of a Patient-Centric, Holistic Endpoint Strategy.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], www.xtalks.com
SOURCE Xtalks
Share this article